Search Results - "Lough, Rachel"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    The topoisomerase II–Hsp90 complex: A new chemotherapeutic target? by Barker, Catherine R., Hamlett, Jane, Pennington, Stephen R., Burrows, Francis, Lundgren, Karen, Lough, Rachel, Watson, Alastair J.M., Jenkins, John R.

    Published in International journal of cancer (01-06-2006)
    “…The modulation of DNA topology by topoisomerase II plays a crucial role during chromosome condensation and segregation in mitosis and has thus become a highly…”
    Get full text
    Journal Article
  5. 5

    BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance by Zhang, Hong, Neely, Laura, Lundgren, Karen, Yang, Yong‐Ching, Lough, Rachel, Timple, Noel, Burrows, Francis

    Published in International journal of cancer (01-03-2010)
    “…17‐AAG, the first‐generation clinical Hsp90 inhibitor, exhibits promising antitumor activity in clinical studies, but is limited by poor solubility and…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Synthesis and Biological Evaluation of a New Class of Geldanamycin Derivatives as Potent Inhibitors of Hsp90 by Le Brazidec, Jean-Yves, Kamal, Adeela, Busch, David, Thao, Lia, Zhang, Lin, Timony, Gregg, Grecko, Roy, Trent, Katy, Lough, Rachel, Salazar, Tim, Khan, Samina, Burrows, Francis, Boehm, Marcus F

    Published in Journal of medicinal chemistry (15-07-2004)
    “…The heat shock protein Hsp90 has increasingly become an important therapeutic target especially for treatment of cancers. Inhibition of the ATPase activity of…”
    Get full text
    Journal Article